Company Profiles

driven by the PitchBook Platform

Aprea

Description

Developer of target specific drugs for the treatment of cancer with non-functional p53. The company develops the novel anticancer compounds by targeting the tumor suppressor protein p53.

2003

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$30M

Latest Deal Amount

$34M

Total Amount Raised

Description

Developer of target specific drugs for the treatment of cancer with non-functional p53. The company develops the novel anticancer compounds by targeting the tumor suppressor protein p53.

Website:

www.aprea.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

Karolinska Institutet Science Park Nobels väg 3 171 65 SolnaSweden +46 (0)8 508 84 50 4
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Aprea's full profile, request a free trial.

    Aprea Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Aprea Investors (10)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    5AM VenturesVenture CapitalMinority000 0000000 0000
    btov PartnersVenture CapitalMinority000 0000000 0000
    HealthCapVenture CapitalMinority000 0000000 0000
    IndustrifondenVenture CapitalMinority000 0000000 0000
    Karolinska DevelopmentVenture CapitalMinority000 0000000 0000
    5AM Ventures Venture Capital
    btov Partners Venture Capital
    HealthCap Venture Capital
    Industrifonden Venture Capital
    Karolinska Development Venture Capital

    Aprea Executive Team (10)

    NameTitleBoard
    Seat
    Contact
    Info
    Christian SchadePresident & Chief Executive Officer
    Ulf BjorklundChief Executive Officer
    Kimmo SinervoChief Financial Officer, Executive, Business Administration & Consultant
    Lars Abrahmsen Ph.DChief Scientific Officer
    Galina SelivanovaCo-Founder & Deputy Director
    Christian Schade President & Chief Executive Officer
    Ulf Bjorklund Chief Executive Officer
    Kimmo Sinervo Chief Financial Officer, Executive, Business Administration & Consultant
    Lars Abrahmsen Ph.D Chief Scientific Officer
    Galina Selivanova Co-Founder & Deputy Director

    Aprea Board Members (9)

    NameRepresentingRoleSinceContact
    Info
    Bernd Seizinger Ph.DSelfExecutive Chairman000 0000
    Guido Magni MDVersant Venture ManagementPartner & Managing Director000 0000
    Johan Christenson Ph.DHealthCapPartner000 0000
    Jonathan Hepple Ph.DRosetta Capital(London)Partner000 0000
    Klas Wiman Ph.DSelfBoard Member & Co-Founder000 0000
    Bernd Seizinger Ph.D Executive Chairman Self
    Guido Magni MD Partner & Managing Director Versant Venture Management
    Johan Christenson Ph.D Partner HealthCap
    Jonathan Hepple Ph.D Partner Rosetta Capital(London)
    Klas Wiman Ph.D Board Member & Co-Founder Self
    Request full access to PitchBook